Boiron SA, a leading name in the homeopathic industry, is headquartered in France and operates extensively across Europe and beyond. Founded in 1932, the company has established itself as a pioneer in the development and distribution of homeopathic medicines, focusing on natural remedies that cater to a variety of health needs. Boiron's core product offerings include a wide range of homeopathic treatments, such as pellets, ointments, and syrups, which are distinguished by their commitment to quality and efficacy. The company is renowned for its innovative approach to homeopathy, utilising rigorous scientific methods to ensure the highest standards. With a strong market position, Boiron SA has achieved notable milestones, including international expansion and recognition as a trusted brand among healthcare professionals and consumers alike. Its dedication to promoting natural health solutions continues to set it apart in the competitive landscape of the pharmaceutical industry.
How does Boiron SA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Boiron SA's score of 28 is lower than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2020, Boiron SA reported total carbon emissions of approximately 7,160,000 kg CO2e, encompassing Scope 1 and 2 emissions. This figure reflects a reduction from 2017, when emissions were about 8,697,000 kg CO2e, and from 2014, which recorded approximately 8,654,000 kg CO2e. The company has not disclosed specific Scope 3 emissions data. Despite these reductions, Boiron SA has not set any formal reduction targets or climate pledges, indicating a lack of structured initiatives aimed at further decreasing their carbon footprint. The absence of Science-Based Targets Initiative (SBTi) commitments or other reduction initiatives suggests that while the company has made progress in reducing emissions, it may not have a comprehensive strategy in place for future climate action. Overall, Boiron SA's emissions data highlights a positive trend in reducing carbon emissions over recent years, but the lack of formal commitments raises questions about the long-term sustainability of these efforts.
Access structured emissions data, company-specific emission factors, and source documents
| 2014 | 2017 | 2020 | |
|---|---|---|---|
| Scope 1 | - | - | - |
| Scope 2 | - | - | - |
| Scope 3 | - | - | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Boiron SA has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

